Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025)
Creative Medical Technology Holdings (CELZ) posted quarterly Revenue of $3000.0 for Q4 2025, little changed year-over-year from $3000.0 in Q4 2024, and little changed quarter-over-quarter from $3000.0 in Q1 2025.
Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Revenue for 9 consecutive years, with $3000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue changed 0.0% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $3000.0 (down 78.57% YoY), while the FY2025 annual figure was $6000.0, down 45.45% from the prior year.
- Revenue was little changed at $3000.0 in Q4 2025 per CELZ's latest filing, from $3000.0 in the prior quarter.
- Across five years, Revenue topped out at $67754.0 in Q4 2021 and bottomed at $3000.0 in Q4 2023.
- Historically, Revenue has averaged $16862.8 across 5 years, with a median of $9000.0 in 2021.
- Annual changes were most pronounced in 2022 — Revenue surged 450.0% — and 2023, when it slumped 89.09%.
- Creative Medical Technology Holdings' Revenue stood at $67754.0 in 2021, then tumbled by 72.55% to $18600.0 in 2022, then slumped by 83.87% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
- Business Quant data shows CELZ's Revenue at $3000.0 in Q4 2025, $3000.0 in Q1 2025, and $3000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Dec 31, 2022 | 18,600.00 |
| Sep 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 67,754.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | 17,500.00 |
| Sep 30, 2020 | 77,000.00 |
| Jun 30, 2020 | 27,900.00 |
| Mar 31, 2020 | 42,100.00 |
| Dec 31, 2019 | -4,400.00 |
| Sep 30, 2019 | 57,500.00 |
| Jun 30, 2019 | 61,600.00 |
| Mar 31, 2019 | 50,800.00 |